On Tuesday, April 21st, Attorney Chad McLain of Graves McLain appeared via Skype on KTUL’s Good Day Tulsa program to discuss mass tort lawsuits. Watch the segment: Many people are harmed by dangerous drugs or defective medical devices every year. Sometimes, drugs and medical devices are rushed onto the market without fully taking into …
Recently, an $85 million settlement between Teva Pharmaceuticals and the state of Oklahoma was signed by Cleveland County District Judge Thad Balkman. The state maintained that Teva utilized deceptive marketing claims to promote opioids as safe and effective pain relievers while de-emphasizing the addictive properties of the drugs. The funds from the settlement are earmarked …
A Cleveland County District Judge has ruled he will decide Oklahoma’s case against several drug manufacturers for their alleged complicity in the opioid crisis currently gripping the United States in a bench trial. District Judge Thad Balkman made the decision to forego a jury trial during a recent hearing. An official with the office of …
Purdue, the manufacturer of the controversial opioid OxyContin, settled a lawsuit brought by the Oklahoma Attorney General for $270 million. A detailed article on the nature of the landmark settlement is available here. A suit filed by Oklahoma Attorney General Mike Hunter against Purdue Pharma alleged the drug manufacturer—through aggressive marketing of OxyContin—fueled the opioid …
Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According to the United States Food and Drug Administration (FDA), a pharmaceutical manufacturer has recalled multiple lots of Irbesartan. These drugs, …
Drug manufacturer Camber Pharmaceuticals has issued a recall for large quantities of Losartan. An article on this emerging story is available here. Currently, no patients have reported any adverse effects related to potential contamination. Patients are advised to speak with a qualified physician before discontinuing the drug. The National Drug Code (NDC) numbers associated with …
Nearly three years ago, two juries in Philadelphia awarded compensatory damages to clients in two lawsuits against Janssen Pharmaceuticals’ drug Risperdal. Now, both cases are proceeding toward new trials to determine punitive damages. A detailed article on the move appears here. Motion to Block Denied Judge Arnold New of the Philadelphia Court of Common Pleas …
The Food and Drug Administration (FDA) announced on Tuesday, 7/26 that they are revising their boxed warning labels on packages of a class of antibacterial drugs known as fluoroquinolones. The FDA’s boxed warning labels, commonly referred to as “black box” warnings, alert doctors and patients that certain types of drugs or medical devices may pose …
The Food and Drug Administration just issued another Drug Safety Communication alerting doctors and patients about serious health risks associated with several type 2 diabetes medications, including Invokana. The FDA is strengthening warnings about the risk of serious, acute kidney injuries for patients taking type 2 diabetes medications canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo …
